Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Pridgen currently holds 2,917 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Pridgen has been a net buyer of VIRI stock. They have purchased $231.9K and sold $0 worth of shares.
William Pridgen's most recent insider trade was on Feb 26, 2024, when they sold 2,917 shares at $0.00 per share.
William Pridgen serves as Executive at Virios Therapeutics, Inc. (VIRI). They have executed 13 insider transactions totaling $231.9K over their tenure at the company.
William Pridgen holds the position of Executive at Virios Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
William Pridgen has shown a buying trading pattern, with $231.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by William Pridgen was on May 17, 2022, when they purchased $58.9K worth of VIRI shares. This transaction involved 13,450 shares at $4.38 per share.
William Pridgen currently owns 2,917 shares of Virios Therapeutics, Inc. (VIRI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Pridgen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Pridgen has 13 Form 4 filings on record as an insider at Virios Therapeutics, Inc..
Set alerts for William Pridgen and 40,000+ other insiders.